← Leaderboards
Cherie L Marvel
Georgetown University
$4,802,804
Attributed
$5,042,238
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $777.2K · FY2010–25$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,042,238 · 5
By mechanism
R01$3,688,597 · 2
K01$848,625 · 1
R21$478,869 · 1
F31$26,147 · 1
Top collaborators
- Stephen M Laconte2 shared
Most similar at Georgetown University
Same institution · by research overlap
- Patrick Alexander Forcelli$9,201,851
- Ludise Malkova$8,461,599
- Italo Mocchetti$14,386,207
- Jonathan Vivian Dickens$193,461
- Janet E Audrain-McGovern$24,829,618
Others in their field
Top investigators on “Neuroimaging”
- Michael W Weiner · Northern California Institute Res &Educ$161,074,866
- Ronald C Petersen · Mayo Clinic Coll Of Medicine, Rochester$118,102,078
- David R. Weir · University Of Michigan At Ann Arbor$109,946,166
- Paul S. Aisen · Cognition Therapeutics, Inc.$109,939,721
- Sid E O'Bryant · University Of North Texas Hlth Sci Ctr$106,631,927
- Arthur W Toga · University Of Southern California$93,816,501
Research focus
NeuroimagingFunctional Magnetic Resonance ImagingBrainExhibitsBehaviorImpairmentPersonsSkillsLearningRelating To Nervous SystemBaseRecording Of Previous EventsDrug AddictionLightAffectOutcome MeasureCognitiveCognitionCognitive FunctionNeurocognitiveLeadImpaired CognitionAttentionPharmaceutical Preparations
Grant awards (17)
Neuroimaging and blood markers in post treatment Lyme disease with persistent neurologic symptoms$533,288
R01 · FY2025 · AI · contact PI
Neuroimaging and blood markers in post treatment Lyme disease with persistent neurologic symptoms$522,935
R01 · FY2024 · AI · contact PI
Neuroimaging and blood markers in post treatment Lyme disease with persistent neurologic symptoms$573,972
R01 · FY2023 · AI · contact PI
Using real-time fMRI neurofeedback and motor imagery to enhance motor timing and precision in cerebellar ataxia$203,203
R21 · FY2023 · NS · contact PI
Using real-time fMRI neurofeedback and motor imagery to enhance motor timing and precision in cerebellar ataxia$275,666
R21 · FY2022 · NS · contact PI
HIV-Related Neuroplasticity and Attention-to-Reward as Predictors of Real World Function$359,587
R01 · FY2020 · DA · contact PI
HIV-Related Neuroplasticity and Attention-to-Reward as Predictors of Real World Function$382,101
R01 · FY2019 · DA · contact PI
HIV-Related Neuroplasticity and Attention-to-Reward as Predictors of Real World Function$438,629
R01 · FY2018 · DA · contact PI
HIV-Related Neuroplasticity and Attention-to-Reward as Predictors of Real World Function$455,217
R01 · FY2017 · DA · contact PI
HIV-Related Neuroplasticity and Attention-to-Reward as Predictors of Real World Function$422,868
R01 · FY2016 · DA · contact PI
Cerebro-Cerebellar Contributions to Cognitive Function in Drug Addiction$170,403
K01 · FY2014 · DA · contact PI
Cerebro-Cerebellar Contributions to Cognitive Function in Drug Addiction$170,403
K01 · FY2013 · DA · contact PI
Cerebro-Cerebellar Contributions to Cognitive Function in Drug Addiction$170,403
K01 · FY2012 · DA · contact PI
Cerebro-Cerebellar Contributions to Cognitive Function in Drug Addiction$170,403
K01 · FY2011 · DA · contact PI
Cerebro-Cerebellar Contributions to Cognitive Function in Drug Addiction$167,013
K01 · FY2010 · DA · contact PI
IMPLICIT LEARNING OF COVARIATION IN SCHIZOPHRENIA$5,517
F31 · FY2001 · MH
IMPLICIT LEARNING OF COVARIATION IN SCHIZOPHRENIA$20,630
F31 · FY2000 · MH